T. Messai

Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies.

C. Haie-meder, N. Magné, Cyrus Chargari, 2010, Brachytherapy.

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy

T. Messai, R. Crevoisier, B. Dubray, 2013, World Journal of Urology.

New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.

C. Haie-meder, N. Magné, T. Messai, 2008, Cancer treatment reviews.

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy.

T. Messai, R. Crevoisier, S. Koscielny, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Nomogram to predict rectal toxicity following prostate cancer radiotherapy

T. Messai, O. Acosta, J. Castelli, 2017, PloS one.

Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.

T. Messai, D. Lefkopoulos, T. Girinsky, 2011, International journal of radiation oncology, biology, physics.

Étude de la dosimétrie in vivo par semi-conducteurs EPD-20 dans les conditions de l’irradiation corporelle totale

T. Messai, F. Benna, M. Maalej, 2010 .

Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.

Christine Haie-Meder, Isabelle Dumas, C. Haie-meder, 2009, International journal of radiation oncology, biology, physics.

Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study.

T. Messai, K. Mrad, M. Ben abdallah, 2008, Bulletin du cancer.